Centrose
Centrose, a US-based biotech firm, develops and commercializes therapeutics targeting disease cells.
Founded
2007Centrose, a US-based biotech firm, develops and commercializes therapeutics targeting disease cells.
Centrose, founded in Madison, United States, is a biotechnology company focused on developing and commercializing therapeutics that target disease-related cells. The company's core mission is to build safer and more potent treatments for cancer by delivering precision medicines that act on the surface of diseased cells. Their innovative approach leverages the unique protein complexes, or Surfaceome, found on cancer cells, particularly those involving the sodium-potassium ATPase (NKA).
Notable figures affiliated with Centrose include leading scientists and biotech experts who contribute to its cutting-edge research. The company has attracted significant interest from investors in the biotech sector due to its pioneering work in targeting the Surfaceome of cancer cells. Key achievements include the discovery of critical protein interactions on cancer cells, positioning Centrose as a promising player in the oncology therapeutics market. The overall impact of Centrose lies in its potential to revolutionize cancer treatment through precision medicine, offering hope for more effective and safer cancer therapies.
Companies similar to Centrose include Adcentrx Therapeutics, Century Therapeutics, Novasenta and NantBio.
Centrose was founded in 2007.
Centrose's headquarters is located in Madison, WI, US.
Centrose's most recent funding round was for $200k (USD) in August 2017.
As of Aug 10, 2017, Centrose has raised a total of $8.1M (USD).
Centrose has 30 employees as of Feb 5, 2024.
Novasenta
novasenta.com
